Handelsbanken Fonder’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Sell |
22,500
-1,300
| -5% | -$63.5K | ﹤0.01% | 919 |
|
|
2025
Q1 | $1.21M | Hold |
23,800
| – | – | 0.01% | 856 |
|
|
2024
Q4 | $1.07M | Sell |
23,800
-900
| -4% | -$40.6K | ﹤0.01% | 935 |
|
|
2024
Q3 | $916K | Buy |
24,700
+2,500
| +11% | +$92.7K | ﹤0.01% | 987 |
|
|
2024
Q2 | $679K | Sell |
22,200
-5,100
| -19% | -$156K | ﹤0.01% | 1017 |
|
|
2024
Q1 | $794K | Buy |
27,300
+10,600
| +63% | +$308K | ﹤0.01% | 943 |
|
|
2023
Q4 | $460K | Buy |
16,700
+3,400
| +26% | +$93.7K | ﹤0.01% | 1194 |
|
|
2023
Q3 | $298K | Sell |
13,300
-140,000
| -91% | -$3.14M | ﹤0.01% | 1310 |
|
|
2023
Q2 | $6.24M | Sell |
153,300
-38,700
| -20% | -$1.57M | 0.03% | 394 |
|
|
2023
Q1 | $9.3M | Sell |
192,000
-42,000
| -18% | -$2.03M | 0.05% | 338 |
|
|
2022
Q4 | $8.93M | Sell |
234,000
-271,400
| -54% | -$10.4M | 0.06% | 335 |
|
|
2022
Q3 | $25.4M | Sell |
505,400
-15,000
| -3% | -$753K | 0.17% | 151 |
|
|
2022
Q2 | $20.8M | Buy |
520,400
+141,400
| +37% | +$5.66M | 0.14% | 173 |
|
|
2022
Q1 | $14.1M | Buy |
379,000
+5,900
| +2% | +$220K | 0.08% | 243 |
|
|
2021
Q4 | $14.9M | Hold |
373,100
| – | – | 0.07% | 264 |
|
|
2021
Q3 | $13.9M | Buy |
373,100
+1,000
| +0.3% | +$37.2K | 0.07% | 265 |
|
|
2021
Q2 | $15.7M | Buy |
372,100
+1,300
| +0.4% | +$55K | 0.08% | 246 |
|
|
2021
Q1 | $17.6M | Buy |
370,800
+5,000
| +1% | +$237K | 0.1% | 203 |
|
|
2020
Q4 | $22.3M | Sell |
365,800
-11,000
| -3% | -$671K | 0.14% | 156 |
|
|
2020
Q3 | $17.6M | Buy |
376,800
+25,000
| +7% | +$1.17M | 0.13% | 166 |
|
|
2020
Q2 | $17.9M | Buy |
351,800
+29,800
| +9% | +$1.51M | 0.15% | 141 |
|
|
2020
Q1 | $14.4M | Sell |
322,000
-61,000
| -16% | -$2.72M | 0.31% | 90 |
|
|
2019
Q4 | $18.4M | Buy |
383,000
+60,000
| +19% | +$2.88M | 0.32% | 95 |
|
|
2019
Q3 | $10.9M | Buy |
323,000
+53,000
| +20% | +$1.79M | 0.22% | 114 |
|
|
2019
Q2 | $12.2M | Buy |
+270,000
| New | +$12.2M | 0.22% | 117 |
|